Pregnancy glucagon-like peptide 1 predicts insulin but not glucose concentrations
Open Access
- 13 July 2023
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 60 (12) , 1635-1642
Abstract
Aims: Incretin hormones glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP) cause increased insulin secretion in non-pregnant adults, but their role in pregnancy, where there are additional metabolically-active hormones from the placenta, is less clear. The aim of the present study was to assess if fasting and post-load incretin concentrations were predictive of pregnancy insulin and glucose concentrations. Methods: Pregnant women (n = 394) with one or more risk factors for gestational diabetes were recruited at 28 weeks for a 75 g oral glucose tolerance test (OGTT). Glucose, insulin, GLP-1 and GIP were measured in the fasting state and 120 min after glucose ingestion. Results: Fasting plasma GLP-1 concentrations were associated with plasma insulin (standardised β’ 0.393 (0.289–0.498), p = 1.3 × 10–12; n = 306), but not with glucose concentrations (p = 0.3). The association with insulin was still evident when adjusting for BMI (β’ 0.271 (0.180–0.362), p = 1.1 × 10–8; n = 297). Likewise, at 120 min the OGTT GLP-1 concentrations were associated with plasma insulin concentrations (β’ 0.216 (0.100–0.331), p = 2.7 × 10–4; n = 306) even after adjusting for BMI (β’ 0.178 (0.061–0.294), p = 2.9 × 10–3; n = 296), but not with glucose (p = 0.9). GIP concentrations were not associated with insulin or glucose concentrations at either time point (all p > 0.2). In pregnancy plasma GLP-1, but not GIP, concentrations appear to be predictive of circulating insulin concentrations, independently of associations with BMIs. Conclusions: These results suggest that the relationship between insulin and incretins is preserved in pregnancy, but that other factors, such as placental hormones or counter-regulatory hormones, may be more important determinants of glycaemia and gestational diabetes aetiology.Keywords
Funding Information
- Diabetes UK (DUK-HKF 17/0005712)
- European Foundation for the Study of Diabetes (NNF19SA058974)
- NIHR Cambridge Biomedical Research Centre
This publication has 33 references indexed in Scilit:
- Incretins, Pregnancy, and Gestational DiabetesCurrent Pharmaceutical Biotechnology, 2016
- Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolicDiabetic Medicine, 2015
- The role of fatty acids in insulin resistanceLipids in Health and Disease, 2015
- Tissue-based map of the human proteomeScience, 2015
- Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to PregnancyPLOS ONE, 2014
- Assessment of methods and indexes of insulin sensitivityRevista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 2014
- Postpartum reversibility of impaired incretin effect in gestational diabetes mellitusRegulatory Peptides, 2013
- Reduced Time Points to Calculate the Composite IndexDiabetes Care, 2010
- GIP and GLP‐1, the two incretin hormones: Similarities and differencesJournal of Diabetes Investigation, 2010
- Incretin hormones and insulin sensitivityTrends in Endocrinology & Metabolism, 2005